Abstract
Penile cancer is a rare tumor. The annual incidence is estimated to be 1 in 100,000 males, accounting for less than 1% of all cancers in men. Regarding histology it consists of squamous cells in 95% of cases. Treatment modalities include surgery, radiotherapy and chemotherapy. Early diagnosis is important since advanced disease is related not only with worse prognosis but also with impaired quality of life.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mansur D (2013) Cancer of the penis and male urethra. In: Perez and Brady’s principles and practice of radiation oncology, 6th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1345–1354
Schoen EJ, Oehrli M, Colby CJ et al (2000) The highly protective effect of newborn circumcision against invasive penile cancer. Pediatrics 105:E36
Miralles-Guri C, Bruni L, Cubilla AL et al (2009) Human papillomavirus prevalence and type distribution in penile carcinoma. J Clin Pathol 62:870–878
Barroso LF, Wilkins T (2011) Human papillomavirus vaccination in males: the state of the science. Curr Infect Dis Rep 13:175–181
Kumar S, Ananthakrishnan N, Prema V (1998) Predicting regional lymph node metastasis in carcinoma of the penis: a comparison between fine-needle aspiration cytology, sentinel lymph node biopsy and medial inguinal lymph node biopsy. Br J Urol 81:453–457
Schlenker B, Scher B, Tiling R et al (2012) Detection of inguinal lymph node involvement in penile squamous cell carcinoma by 18F-florodeoxyglucose PET/CT: a prospective single-center study. Urol Oncol 30(1):55–59
Graafland NM, Leijte JAP, Valdes Olmos RA et al (2009) Scanning with 18F-FDG-PET/ CT for detection of pelvic nodal involvement in inguinal node- positive penile carcinoma. Eur Urol 56:339–345
Villavicencio H, Rubio-Briones J, Regalado R et al (1997) Grade, local stage and growth pattern as prognostic factors in carcinoma of the penis. Eur Urol 32:442–447
Shapiro D, Shasha D, Tareen M et al (2011) Contemporary management of localized penile cancer. Expert Rev Anticancer Ther 11(1):29–36
Solsana E, Bahl A, Brandes SB et al (2010) New developments in the treatment of localized penile cancer. Urology 76(2, Suppl 1):S36–S42
Colberg JW, Andriole GL, Catalona WJ (1997) Long-term follow-up of men undergoing modified inguinal lymphadenectomy for carcinoma of the penis. Br J Urol 79:54–57
Solsona E, Iborra I, Rubio J et al (2001) Prospective validation of the association of local tumor stage and grade as a predictive factor for occult lymph node micrometastasis in patients with penile carcinoma and clinically negative inguinal lymph nodes. J Urol 165:1506–1509
Perinetti E, Crane DB, Catalona WJ (1980) Unreliability of sentinel lymph node biopsy for staging penile carcinoma. J Urol 124:734–735
Protzel C, Seitz AK, Hakenberg OW et al (2013) Neoadjuvant, adjuvant and palliative chemotherapy of penile cancer. Urologe A 52(11):1556–1560
Zanetta G, Lissoni A, Pellegrino A et al (1998) Neoadjuvant chemotherapy with cisplatin, ifosfamide and paclitaxel for locally advanced squamous-cell cervical cancer. Ann Oncol 9(9):977–980
Sonpavde G, Pagliaro LC, Buonerba C et al (2013) Penile cancer: current therapy and future directions. Ann Oncol 24(5):1179–1189
Pagliaro LC, Williams DL, Daliani D et al (2010) Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study. J Clin Oncol 28(24):3851–3857
Langsenlehner T, Mayer R, Quehenberger F, Prettenhofer U, Langsenlehner U, Pummer K, Kapp KS (2008) The role of radiation therapy after incomplete resection of penile cancer. Strahlenther Onkol 184(7):359–363
Johnson TV, Hsiao W, Delman KA, Jani AB, Brawley OW, Master VA (2010) Extensive inguinal lymphadenectomy improves overall 5-year survival in penile cancer patients: results from the Surveillance, Epidemiology, and End Results program. Cancer 116(12):2960–2966
Wood DP (2011) Re: extensive inguinal lymphadenectomy improves overall 5-year survival in penile cancerpatients: results from the surveillance, epidemiology, and end results program. J Urol 185(4):1282
Burt LM, Shrieve DC, Tward JD (2014) Stage presentation, care patterns, and treatment outcomes for squamous cell carcinoma of the penis. Int J Radiat Oncol Biol Phys 88(1):94–100
Crook J, Mazeron JJ (2012) Penile Cancer. In: Gunderson L, Tepper J (eds) Clinical radiation oncology, 3rd edn. Elsevier Saunders, Philadelphia, pp 1167–1176
De Crevoisier R, Slimane K, Sanfilippo N et al (2009) Long-term results of brachytherapy for carcinoma of the penis confined to the glans (N- or NX). Int J Radiat Oncol Biol Phys 74:1150–1156
Delaunay B, Soh PN, Delannes M et al (2014) Brachytherapy for penile cancer: efficacy and impact on sexual function. Brachytherapy 13(4):380–387
Hasan S, Francis A, Hagenauer A, Hirsh A, Kaminsky D, Traughber B, Abouassaly R, Ellis R (2015) The role of brachytherapy in organ preservation for penile cancer: a meta-analysis and review of the literature. Brachytherapy 1538–4721(15):00456
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Tsoukalas, N., Tsapakidis, K., Kyrgias, G., Tolia, M. (2019). Penile Cancer. In: De Mello, R., Mountzios, G., Tavares, Á. (eds) International Manual of Oncology Practice. Springer, Cham. https://doi.org/10.1007/978-3-030-16245-0_30
Download citation
DOI: https://doi.org/10.1007/978-3-030-16245-0_30
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-16244-3
Online ISBN: 978-3-030-16245-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)